High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
about
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
High ten-year remission rates ...... Results of a randomized Study.
@en
type
label
High ten-year remission rates ...... Results of a randomized Study.
@en
prefLabel
High ten-year remission rates ...... Results of a randomized Study.
@en
P2093
P2860
P356
P1476
High ten-year remission rates ...... Results of a randomized Study.
@en
P2093
Andre H Goy
Eleanor Neal
Felipe Samaniego
Fredrick B Hagemeister
Jorge E Romaguera
Loretta J Nastoupil
Luis Fayad
Maria A Rodriguez
P2860
P304
P356
10.1111/BJH.14541
P407
P577
2017-03-24T00:00:00Z